581 related articles for article (PubMed ID: 23928669)
21. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
Homburg R; Ray A; Bhide P; Gudi A; Shah A; Timms P; Grayson K
Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771
[TBL] [Abstract][Full Text] [Related]
22. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?
Catteau-Jonard S; Bancquart J; Poncelet E; Lefebvre-Maunoury C; Robin G; Dewailly D
Ultrasound Obstet Gynecol; 2012 Aug; 40(2):223-9. PubMed ID: 22648908
[TBL] [Abstract][Full Text] [Related]
23. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome.
Somunkiran A; Yavuz T; Yucel O; Ozdemir I
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):196-201. PubMed ID: 17335955
[TBL] [Abstract][Full Text] [Related]
24. Increased androgen, anti-Müllerian hormone, and sporadic anovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype?
Sjaarda LA; Mumford SL; Kissell K; Schliep KC; Hammoud AO; Perkins NJ; Weck J; Wactawski-Wende J; Schisterman EF
J Clin Endocrinol Metab; 2014 Jun; 99(6):2208-16. PubMed ID: 24606085
[TBL] [Abstract][Full Text] [Related]
25. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
[TBL] [Abstract][Full Text] [Related]
26. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.
Nybacka Å; Carlström K; Fabri F; Hellström PM; Hirschberg AL
Fertil Steril; 2013 Oct; 100(4):1096-102. PubMed ID: 23876536
[TBL] [Abstract][Full Text] [Related]
27. The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes.
Romualdi D; Di Florio C; Tagliaferri V; De Cicco S; Gagliano D; Immediata V; Lanzone A; Guido M
Reprod Sci; 2016 May; 23(5):655-61. PubMed ID: 26718304
[TBL] [Abstract][Full Text] [Related]
28. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I
Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
[TBL] [Abstract][Full Text] [Related]
29. Comparison of serum anti-Müllerian hormone levels in normal weight and overweight-obese adolescent patients with polycystic ovary syndrome.
Cengiz H; Ekin M; Dagdeviren H; Yildiz Ş; Kaya C; Kanawati A
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():46-50. PubMed ID: 25036408
[TBL] [Abstract][Full Text] [Related]
30. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.
Chen MJ; Yang WS; Chen CL; Wu MY; Yang YS; Ho HN
Hum Reprod; 2008 Apr; 23(4):952-7. PubMed ID: 18256110
[TBL] [Abstract][Full Text] [Related]
31. Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS.
Rudnicka E; Kunicki M; Calik-Ksepka A; Suchta K; Duszewska A; Smolarczyk K; Smolarczyk R
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830389
[TBL] [Abstract][Full Text] [Related]
32. Circulating Anti-Müllerian Hormone Levels in Daughters of Women with and without Polycystic Ovary Syndrome.
Olszanecka-Glinianowicz M; Zachurzok A; Drosdzol-Cop A; Bożętowicz-Wikarek M; Owczarek A; Gawlik A; Chudek J; Skrzypulec-Plinta V; Małecka-Tendera E
Horm Res Paediatr; 2016; 85(6):372-8. PubMed ID: 27173495
[TBL] [Abstract][Full Text] [Related]
33. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P
Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474
[TBL] [Abstract][Full Text] [Related]
34. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
Bradbury RA; Lee P; Smith HC
Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
[TBL] [Abstract][Full Text] [Related]
35. Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study.
Tagliaferri V; Romualdi D; Scarinci E; Cicco S; Florio CD; Immediata V; Tropea A; Santarsiero CM; Lanzone A; Apa R
Reprod Sci; 2018 Feb; 25(2):269-275. PubMed ID: 28558523
[TBL] [Abstract][Full Text] [Related]
36. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
Yang S; Ruan J; Huang W; Tan J; Zhang X; Feng X; Liu D; Fu J; Zhou L; Zhou M
Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
[TBL] [Abstract][Full Text] [Related]
37. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
Sova H; Unkila-Kallio L; Tiitinen A; Hippeläinen M; Perheentupa A; Tinkanen H; Puukka K; Bloigu R; Piltonen T; Tapanainen JS; Morin-Papunen L
Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196
[TBL] [Abstract][Full Text] [Related]
38. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
[TBL] [Abstract][Full Text] [Related]
39. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
[TBL] [Abstract][Full Text] [Related]
40. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F
Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
